Literature DB >> 20881211

The emerging scientific discipline of pharmacometrics.

Marc Pfister, David Z D'Argenio.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20881211     DOI： 10.1177/0091270010377789

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  6 in total

1.  Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics.

Authors:  David Z D'Argenio; Marc R Gastonguay; Richard C Brundage; Raymond Miller; Stacey J Tannenbaum; Marc Pfister
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-02       Impact factor: 2.745

2.  Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model.

Authors:  C Steven Ernest; Joakim Nyberg; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-12       Impact factor: 2.745

Review 3.  Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children.

Authors:  Frederique Rodieux; Melanie Wilbaux; Johannes N van den Anker; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

Review 4.  Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Authors:  Eva Germovsek; Charlotte I S Barker; Mike Sharland; Joseph F Standing
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 5.577

5.  Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.

Authors:  Lina Keutzer; Huifang You; Ali Farnoud; Joakim Nyberg; Sebastian G Wicha; Gareth Maher-Edwards; Georgios Vlasakakis; Gita Khalili Moghaddam; Elin M Svensson; Michael P Menden; Ulrika S H Simonsson
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

6.  Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study.

Authors:  Gilbert Koch; Britta Steffens; Stephanie Leroux; Verena Gotta; Johannes Schropp; Pascal Gächter; Freya Bachmann; Tatjana Welzel; Marco Janner; Dagmar L'Allemand; Daniel Konrad; Gabor Szinnai; Marc Pfister
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-06-11       Impact factor: 2.745
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.